Emily Kalenik

Bio

Emily joined OrbiMed in 2021 and is a Vice President focused on structured finance and healthcare royalty investments. Prior to joining OrbiMed, Emily was an Associate in Goldman Sachs’ Healthcare Investment Banking Group where she focused on M&A and equity transactions. Previously, she was a consultant at Accenture in the Life Sciences Strategy group. Emily holds an M.B.A. in Healthcare Management from Wharton and a B.A. in the Biological Basis of Behavior from the University of Pennsylvania.